P. Villeneuve

Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia

C. Bredeson, M. Sabloff, P. Berardi, 2021, Leukemia & lymphoma.

Economic Evaluation of Azacitidine in Elderly Patients with Acute Myeloid Leukemia with High Blast Counts

D. Coyle, P. Villeneuve, 2019, PharmacoEconomics - Open.

Comparison of autofluorescence and white-light bronchoscopies performed with the Evis Lucera Spectrum for the detection of bronchial cancers: a meta-analysis

Y. Mohammad, G. Wagnières, E. Barreiro, 2020, Translational lung cancer research.

CAR-T Cells in Canada; Perspective on How to Ensure We Get Our Value’s Worth

C. Bredeson, P. Villeneuve, 2023, Current oncology.